• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2021 September

Post Archive by Month

View Post

Pharmacies Often Not Notified of Discontinued Rx

In HealthDay News, OBGYN & Women's Health
by Healthday
September 29, 2021

Interventions, including phoning pharmacies and enabling CancelRX in electronic medical records, may reduce risk for medication safety events

View Post

Taxane-Containing Chemo Associated With Persistent Alopecia

In HealthDay News, OBGYN & Women's Health
by Healthday
September 29, 2021

However, many patients experience improvements in hair density with standard alopecia treatments

View Post

FDA Takes New Action to Improve Quality, Efficacy of Sunscreens

In HealthDay News
by Healthday
September 29, 2021

Proposed changes include updates to safe active ingredients and broad spectrum requirements

View Post

Live Attenuated Zoster Vaccine Safe for Patients Receiving TNF Inhibitors

In HealthDay News
by Healthday
September 27, 2021

No cases of varicella infection found; cumulative incidence of varicella infection or shingles was 0 percent

View Post

Vaccines Effective in Preventing Symptomatic COVID-19 in Health Care Workers

In HealthDay News, OBGYN & Women's Health
by Healthday
September 27, 2021

Findings seen even for those at risk for severe disease and racial and ethnic groups disproportionately affected by the pandemic

View Post

Overall Cancer Incidence, Mortality Lower for U.S. Hispanics

In HealthDay News, OBGYN & Women's Health
by Healthday
September 24, 2021

But rates higher for infection-related cancers, such as liver and stomach cancers, and cervical cancer

View Post

Incidence of Psoriatic Arthritis Up With More Severe Psoriasis

In HealthDay News
by Healthday
September 22, 2021

Incidence of psoriatic arthritis increases with increasing severity of psoriasis stratified by treatment severity surrogates

View Post

Precedent Needed for FDA Approval Decisions When Evidence Lacking

In HealthDay News, OBGYN & Women's Health
by Healthday
September 21, 2021

In seven of 22 cases, approval used new interpretations of original evidence and did not require new evidence

View Post

Adjuvant Pembrolizumab Cuts Recurrence in Stage II Melanoma

In HealthDay News
by Healthday
September 20, 2021

Compared with placebo, pembrolizumab prolonged regression-free survival in resected high-risk stage IIB and IIC melanoma

View Post

Americans Struggling With High Cost of Prescription Drugs

In HealthDay News, OBGYN & Women's Health
by Healthday
September 20, 2021

Adults younger than 65 years twice as likely to report not filling needed prescriptions due to cost versus seniors

  • Page 1 of 3
  • 1
  • 2
  • 3
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

September 2021
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
« Aug   Oct »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer